High-Precision Central Nervous System Model for Drug Discovery | ZEFIT

ZEFIT a biopharmaceutical company, uses innovative zebrafish models to accelerate preclinical research, focusing on neurological disorders, and delivers efficient solutions for drug screening and early-stage development. The central nervous system model is a research Platform for studying neurological disorders and drug discovery, by using zebrafish models to accurately evaluate neurological phenotypes like locomotion, neural structure, and cognitive functions. 

 

Key Features of the Central Nervous System Model: 

  • Comprehensive neurological assessments are performed to accurately and cost-effectively evaluate locomotion, neural structures, and cognitive functions. 



  • Zebrafish are a reliable model for neurological research due to their shared conserved CNS genes with humans. 



  • Transparent zebrafish embryos enable in vivo monitoring of brain activity and disease progression, providing non-invasive and real-time monitoring. 


Advanced Data Analytics are employed to generate large-scale datasets for in-depth analysis of neurological phenotypes, as well as estimation of drug responses 

  • By focusing on disease-specific behaviors and electrophysiological changes, targeted disease research offers crucial insights into Alzheimer’s disease (AD), Parkinson’s disease (PD), and epilepsy. 



  • The CNS-FITTM model provides a reliable preclinical system for evaluating potential drug compounds for CNS disorders. 



  • Efficient preclinical validation ensures a reliable evaluation of potential drug candidates for CNS disorders before they proceed to clinical trials. 


 

If you are looking for a reliable and effective central nervous system model, you can find it at ZEFIT. 

 

Click here if you have any questions in ZEFIT services. 

 

View more: High-Precision Central Nervous System Model for Drug Discovery 

Leave a Reply

Your email address will not be published. Required fields are marked *